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Abstract
Background: Chromosomal complement, including that provided by the sex chromosomes, influences expression
of proteins and molecular signaling in every cell. However, less than 50% of the scientific studies published in 2009
using experimental animals reported sex as a biological variable. Because every cell has a sex, we conducted a
literature review to determine the extent to which sex is reported as a variable in cardiovascular studies on
cultured cells.
Methods: Articles from 10 cardiovascular journals with high impact factors (Circulation, J Am Coll Cardiol, Eur Heart
J, Circ Res, Arterioscler Thromb Vasc Biol, Cardiovasc Res, J Mol Cell Cardiol, Am J Physiol Heart Circ Physiol, J Heart
Lung Transplant and J Cardiovasc Pharmacol) and published in 2010 were searched using terms ‘cultured’ and ‘cells’
in any order to determine if the sex of those cells was reported. Studies using established cell lines were excluded.
Results: Using two separate search strategies, we found that only 25 of 90 articles (28%) and 20 of 101 articles
(19.8%) reported the sex of cells. Of those reporting the sex of cells, most (68.9%; n = 31) used only male cells and
none used exclusively female cells. In studies reporting the sex of cells of cardiovascular origin, 40% used vascular
smooth-muscle cells, and 30% used stem/progenitor cells. In studies using cells of human origin, 35% did not
report the sex of those cells. None of the studies using neonatal cardiac myocytes reported the sex of those cells.
Conclusions: The complement of sex chromosomes in cells studied in culture has the potential to affect
expression of proteins and ‘mechanistic’ signaling pathways. Therefore, consistent with scientific excellence,
editorial policies should require reporting sex of cells used in in vitro experiments.
Background
In 2001, the Institute of Medicine published a landmark
report identifying the importance of sex as a biological
variable in experimental and human studies [1]. Over a
decade later, the effect of this report remains to be rea-
lized, as few clinical trials report outcomes stratified by
sex [2,3], and only 22-42% of studies published in jour-
nals on neuroscience, endocrinology, physiology, phar-
macology, reproductive medicine, and general biology
reported the sex of the experimental animals used [4].
Cultured cells are used to identify molecular-signaling
pathways. Results from such studies are often used as
the basis for development of new therapeutic, diagnos-
tic, and other interventions for translation to human
medicine. Because every cell has a sex [1], and the com-
plement of sex chromosomes has the potential to influ-
ence expression of proteins and other signaling
m o l e c u l e s[ 5 - 1 2 ] ,w eu n d e r t o o kal i t e r a t u r er e v i e wt o
determine how sex was reported for in vitro experi-
ments. The review was limited to journals publishing
studies in cardiovascular research, because cardiovascu-
lar disease remains the foremost cause of mortality for
both women and men, and there remains a significant
disparity in all-cause mortality from cardiovascular dis-
ease between women and men in the USA [13,14].
Some of the disparity in all-cause mortality from cardio-
vascular disease may result from socioeconomic issues
and access to health care. However, other factors contri-
buting to the disparity include sex differences in presen-
tation of symptoms (such as those related to myocardial
infarction and stroke [15]), ineffective or adverse
response to treatments (side-effects related to angioten-
sin-converting enzyme inhibitors, treatment for
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female-predominant diseases including heart failure with
preserved ejection fraction (HFpEF) [14,16]) and pre-
sence of cardiovascular diseases unique to women (such
as hypertension disorders of pregnancy [17]). The phy-
siological, cellular and molecular bases of how these fac-
tors contribute to sex disparity in all-cause mortality
remain to be explored.
Methods
Search strategy
In order to emphasize how the practice of various edi-
torial committees and policies affect the reporting and
transfer of knowledge to the cardiovascular scientific
community, the cardiovascular journals with the top
impact factors under the subject category ‘cardiac and
cardiovascular systems’ were selected from the ISI Web
of Knowledge website under the 2009 JCR Science edi-
tion. The list was limited to journals with the top 40
impact factors, and then narrowed in sequential des-
cending order to those journals that published original
basic science articles, eliminating journals that published
only review articles. Journals were selected in descend-
ing order of impact factor: Circulation; Journal of Amer-
ican College of Cardiology (J Am Coll Cardiol);
European Heart Journal (Eur Heart J); Circulation
Research (Circ Res); Arteriosclerosis, Thrombosis and
Vascular Biology (Arterioscler Thromb Vasc Biol); Cardi-
ovascular Research (Cardiovasc Res); Journal of Molecu-
lar and Cellular Cardiology (J Mol Cell Cardiol);
American Journal of Physiology - Heart and Circulatory
Physiology (Am J Physiol Heart Circ Physiol); Journal of
Heart and Lung Transplantation (J Heart Lung Trans-
plant); and Journal of Cardiovascular Pharmacology (J
Cardiovasc Pharmacol). The journal Arteriosclerosis,
Thrombosis and Vascular Biology was not listed under
the subject category mentioned above; however, because
of its high impact factor in the cardiovascular field, it
was included.
The search terms ‘cultured’ and ‘cells’ were used in
any order, and were limited to the title, abstract and
text, using specific journal websites or, in some cases,
the medium used by these journals for their searches,
such as Science Direct. The year was limited to ‘2010’
or to the issue(s) that corresponded to the year 2010.
Results from these searches then were sorted by best
match (relevance). Only original, full-length articles
were reviewed; reviews, letters and brief communica-
tions were excluded. Two types of searches were
conducted.
In the first search, the Methods sections were
reviewed for indication of use of cultured cells. Only
studies that utilized primary cultures (that is, cells iso-
lated from animals and subsequently cultured) were
included. Additionally, we also excluded any articles for
which the Methods section was not clear regarding the
use of cells isolated from animals for culturing purposes.
For each journal, the first 10 articles that satisfied these
specifications were included in the analysis. One journal
was omitted from the analysis because it did not have
10 articles meeting the inclusion criteria for the year
2010. From this first search, 90 articles meeting our
inclusion criteria were identified.
In the second search, the top 10 journals were
searched again using the terms ‘culture’ and ‘cells’ in
any order for best match (relevance), but the supple-
mental material was also reviewed and articles were lim-
ited to those using either endothelial cells (ECs),
vascular smooth-muscle cells (VSMCs), cardiomyocytes
(including neonatal cardiomyocytes), and cardiac fibro-
blasts (including neonatal cardiac fibroblasts), as well as
stem cells with a clear indication of differentiation into
a cardiac lineage. Additionally, the number of articles
from two randomly selected journals (Cardiovasc Res
and J Mol Cell Cardiol), were increased to 20, in order
to reduce potential sampling bias. As a result of this
second strategy, 101 articles were reviewed, but the
number of articles per journal varied.
Data collection
Data were collected on the sex of cells, scored as ‘yes’
for sex reported and ‘no’ for no sex reported. The ‘yes’
was further categorized into males, females, or both.
Additionally, the species from which the cells were iso-
lated and the type of cells used were recorded.
Results
From this survey of the top 10 cardiovascular journals
based on impact factor, we found that reporting the sex
of the cells used in experiments is not standard. Using
the first search strategy, we found that only 25 articles
(28%) of the 90 articles surveyed reported the sex of
cells used in the experiments.
Using the second search strategy, we identified 101
articles from 10 journals; only 20 of these articles
(19.8%) reported the sex of the cells used in the experi-
ments (Figure 1). Of those articles that reported the sex
of cells, 85% did so within the body of the article,
whereas 15% of articles reported it within ‘supplemental
material.’ The numbers also varied between journals:
half of the articles surveyed from Am J Physiol Heart
Circ Physiol and J Cardiovasc Pharmacol reported the
sex of cells used in the experiments, compared with
none of the articles in this survey from Eur Heart J and
JA mC o l lC a r d i o l . Reporting of sex in the other jour-
nals reviewed ranged from 10% to 40% of the total (Fig-
ure 1).
Of the 20 articles from the second search in which sex
was reported, male cells predominated, and were used in
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Page 2 of 765% of these articles, whereas cells from both sexes were
used in only 35%. None of the studies used exclusively
female cells. For instance in Am J Physiol Heart and
Circ Physiol, two of the five articles reporting the sex of
the cells used cells derived from male animals; the
remaining three studies used cells from both sexes. By
contrast, studies published in Cardiovasc Res,t h ej o u r -
nal with the lowest percentage of sex reporting, used
cells from male animals only.
The species of the cells were reported in all studies (n
= 191), even those that did not report sex. The cell
types reported were: human, rodent (rats and mice),
bovine, porcine, ovine, rabbit, primates and canine. The
sex of cells derived from rats was reported most often
whereas the sex of cells derived from humans was
reported least often (Figure 2).
None of the articles that reported the sex of the cells
had used neonatal cardiomyocytes. ECs and VSMCs
were the cell types used most often in studies that did
not report sex, and VSMCs were those used most
often in the articles that did report the sex of cells
(Figure 3).
Discussion
The results of this literature review indicate that in car-
diovascular specialty journals with high impact factors,
sex, despite being a biological variable that could affect
outcomes, interpretation and applicability of data, is not
reported consistently. This observation parallels the
absence of reporting of sex found in journals and arti-
cles reporting results of studies using animals and of
human clinical trials [2-4]. Unlike the analysis of articles
using experimental animals, which covered a variety of
disciplines, the present search reviewed only articles
reported in journals with a cardiovascular focus. There-
fore, it is not possible to extrapolate these findings to
journals that publish articles using cultured cells in
other disciplines, or to the use of other search strategies
with different inclusion/exclusion criteria for sampling.
However, this sample included a variety of journals,
Unspecified
Male & 
Female Male
% Articles Reporting Sex of Cells
02 0 4 06 0 8 0 1 0 0
Circulation            (n = 10)
J Am Coll Cardiol (n = 6)
Eur Heart J          (n = 7)
Circ Res             (n = 10)
Arterioscler Thromb Vasc Biol (n = 10)
Cardiovasc Res      (n = 20)
J Mol Cell Cardiol (n = 20)
Am J Physiol Heart Circ Physiol (n = 10)
J Heart Lung Transplant      (n = 4)
J Cardiovasc Pharmacol (n = 4)
Figure 1 Percentage of articles reporting sex of cells used in the experiments. Percentage of articles reporting sex of cells used in the
experiments. n = Number of articles reviewed per journal. None of the studies reviewed used only cells from female animals.
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A. Sex Reported (%) 
Mouse  Rat  Human  Porcine  Rabbit 
Ovine  Bovine  Canine  Monkey 
B. No Sex Reported (%) 
52 
14 
10 
5  19  4  20 
28  35 
4 
2  5  1 1 
Figure 2 Representation of the species for source of cells. Representation of the species for source of cells (by percentage) which (A)
reported (n = 20 articles) and (B) did not report (n = 81) the sex of cells in 101 articles reviewed by the second search strategy. Some studies
used cells from more than one species. (A) In studies that reported the sex of the cells, most used cells derived from rats, whereas (B) in studies
that did not report sex, most cells were derived from humans.
Types of Cells 
A. Sex Reported (%) 
Cardiomyocytes  Endothelial cells  Vascular smooth muscle cells 
Stem cells/progenitor cells  Cardiac fibroblasts  Neonatal cardiomyocytes 
Neonatal fibroblasts 
B. No Sex Reported (%) 
40 
30 
10  5 
15 
18 
22  18 
2 
22 
15 
3 
Figure 3 Representation of cell types. Representation of cell types (by percentage) which (A) reported (n = 20 articles) and (B) did not report
(n = 81) the sex of cells in 101 articles reviewed by the second search strategy. Some studies used more than one type of cell. (A) In studies
reporting the sex of the cells, most used vascular smooth-muscle cells, whereas in studies that did not report the sex of cells, most used
endothelial cells and vascular smooth-muscle cells.
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ers and by not-for-profit entities (such as professional
societies), and those with international editorial boards.
Because the same results were obtained from one jour-
nal reviewed by two independent researchers using dif-
ferent strategies (as an internal control), it is unlikely
that our results were biased by reviewer or strategy.
In the United States, Canada and the European Union,
regulatory mandates require inclusion of women in clin-
ical trials. Similar mandates do not exist for preclinical
or basic studies. Because studies using cells in culture
are considered a first step in the identification of
mechanistic and molecular approaches for drug discov-
ery, it is important to identify those pathways and con-
ditions for which the sex of the cell may influence gene
expression and potential therapeutic molecular targets.
Based on the results of this review, there seems to be an
assumption that the sex of cells in culture is not impor-
tant or is a detail that does not warrant reporting. This
assumption is false, given the evidence that sex influ-
ences expression of genes in some cultured cells, tissues,
organs and diseases, including cardiovascular disease
[7,8,12,13,18-20]. In 2001, the General Accounting
Office reported that pharmaceuticals withdrawn from
the market in the USA had greater health risks for
women than men (GAO-01-286R). Evaluations have not
been performed on pharmaceuticals withdrawn from the
market since the dates covered in the 2001 report. How-
ever, the possibility exists that identification of sex dif-
ferences in molecular targets and cellular responses in
the initial, often less expensive, stages of drug develop-
ment might identify new targets that could reduce
adverse side-effects in clinical testing. Indeed, adverse
drug events as collected by the Italian Agency of Drugs
have been found to be greater in women than men
(2010 statistics). In 2011, the Italian Medicines Agency
(AIFA) established a Working Group on Medicines and
Gender for the purpose of studying issues related to reg-
ulatory and pharmacological issues in gender medicine.
In this era of genomics, the concept that the comple-
ment of sex chromosomes might influence outcomes/
results of experimental studies using cultured cells
seems fundamental. Journals do not have specific poli-
cies requiring reporting of the sex of cells, even though
other experimental details (such as culture conditions of
temperature, oxygen tension and media) are reported
(Table 1). It is likely that researchers, reviewers and edi-
tors simply do not think about sex as an important bio-
logical variable in the experimental design [21]. There is
often the assumption and rationale that inclusion of
Table 1 ’Instruction to Authors’ and editorial policy for journals from which reviewed articles were obtained.
Journal Publisher Policy
Circulation American Heart Association ’Experimental animals: State the species, strain, number used and pertinent descriptive
characteristics.’
J Am Coll Cardiol Official Journal of the American College
of Cardiology/Elsevier
’Manuscript submissions should conform to the guidelines set forth in the “Uniform
Requirements for Manuscripts Submitted Biomedical Journals: Writing and Editing for
Biomedical Publication”... Animal investigations must conform to the “Position of the
American Heart Association on Research Animal Use"’
Eur Heart J Official Journal of European Society of
Cardiology/Oxford Journals
No specific information in Instruction to Authors
Circ Res American Heart Association ’Expanded Methods section must... be detailed enough to enable readers to replicate
the experiments without consulting previous articles... For animals used in experiments,
state the species, strain, number used and other pertinent descriptive characteristics.’
Arterioscler
Thromb Vasc Biol
American Heart Association ’...state the species, strain, number used and other pertinent descriptive characteristics.’
Cardiovasc Res Oxford Journals ’....procedures with animals or animal tissues, investigations conform to either the
Guide for the Care and Use of Laboratory Animals... or the Directive 2010/63/EU.’
J Mol Cell Cardiol Official Journal of the International
Society for Heart Research/Elsevier
’the use of animals...the authors should ensure that the manuscript contains a
statement that procedures were performed in compliance with relevant laws and
institutional guidelines... ‘
Am J Physiol
Heart Circ Physiol
American Physiological Society ’Describe techniques, cell/animal models used’
J Heart Lung
Transplant
Elsevier ’All manuscripts reporting experiments using animals must include a statement in the
Methods section giving assurance that all animals received humane care in compliance
with the “Principles of Laboratory Animal Care” formulated by the National Society for
Medical Research and the “Guide for the Care and Use of Laboratory Animals”
prepared by the Institute of Laboratory Animal Resources and published by the
National Institutes of Health (NIH Publication No.86-23, revised 1996).’
J Cardiovasc
Pharmacol
Wolters Kluwer/Lippincott/
Williams & Wilkins
’... studies on experimental animals have been conducted under protocols reviewed
and approved by the author’s institutional animal care and use committee and to
adhere to generally accepted international guidelines for animal experimentation.’
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comes relative to male material. This assumption war-
rants questioning, as does the procedure of culturing
male cells in media such as fetal calf serum, which con-
tains large amounts of female sex-steroid hormones
unless stripped in charcoal. Material from neonatal ani-
mals is studied to understand factors contributing to
cellular differentiation; in this survey, none of the stu-
dies using cardiac myocytes or fibroblasts from neonatal
animals reported the sex of the neonates even though it
is possible to sex these animals using anogenital distance
[22]. The use of cultures of cells of mixed sex assumes
equal viability, function and differentiation for cells of
male and female animals. This assumption requires vali-
dation, as genes on the Y chromosome may affect risk
for cardiovascular disease [23-25], and genes on the X
chromosome may affect responses to hypoxia and apop-
tosis, processes involved in cardiac performance
[9-11,26,27].
Although this survey focused specifically on reporting
of the sex of cultured cells, it should be mentioned that
it is possible that the gene expression of these cells may
be set or influenced by the hormonal environment of
the animal from which the cells were derived. For exam-
ple, long-lasting effects of hormones on cellular function
have been explored in other systems [28-30]. These
issues have yet to be considered in studies of cardiovas-
cular cells. Thus, for example, it remains to be deter-
mined whether cultured human umbilical-vein ECs are
representative of ECs derived from an adult or aged
male or from a null- or multi-parous female. As indi-
cated in the 2001 Institute of Medicine report [1], sex,
age and hormonal status need to be considered in
experimental design.
The editors of scientific journals and the publication
committees of professional societies are in the position
to direct change for a broader inquiry into sex-driven
mechanisms of disease by requiring reporting of the
sex of the experimental material used and the analysis
of data by sex [21]. Authors are accustomed to having
to include in their Methods sections statements of
institutional approval for use of animals or humans,
funding sources and conflict of interest. Although
those items are important to insure the objectivity of
and regulations for the conduct of the study, they are
unlikely to directly affect the results of the experiments
or to allow others to replicate their experiments, a tra-
ditional requirement for scientific validity. Perhaps it is
time to require reporting of the sex of the material
used in studies. Not only might sex affect experimental
outcome, but reporting such a fundamental component
of the experimental design is consistent with scientific
excellence.
Conclusion
Sex is not consistently reported as a variable in studies
using cultured cells to investigate mechanisms of cardio-
vascular physiology and disease. The editorial policies of
scientific journals should require reporting of sex as a
genetic variable and as a fundamental condition of
scientific excellence.
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